Skip to main content

Local AIDS Pharmaceutical Assistance Program

Local AIDS Pharmaceutical Assistance Program

HRSA Service Definition

AIDS Pharmaceutical Assistance services fall into two categories, based on RWHAP Part funding.

1. Local Pharmaceutical Assistance Program (LPAP) is operated by a RWHAP Part A or B recipient or sub-recipient as a supplemental means of providing medication assistance when an ADAP has a restricted formulary, waiting list and/or restricted financial eligibility criteria.

RWHAP Part A or B recipients using the LPAP service category must establish the following:

  • Uniform benefits for all enrolled clients throughout the service area
  • A recordkeeping system for distributed medications
  • An LPAP advisory board
  • A drug formulary approved by the local advisory committee/board
  • A drug distribution system
  • A client enrollment and eligibility determination process that includes screening for ADAP and LPAP eligibility with rescreening at minimum of every six months
  • Coordination with the state’s RWHAP Part B ADAP
    • A statement of need should specify restrictions of the state ADAP and the need for the LPAP
  • Implementation in accordance with requirements of the 340B Drug Pricing Program and the Prime Vendor Program

2. Community Pharmaceutical Assistance Program is provided by a RWHAP Part C or D recipient for the provision of long-term medication assistance to eligible clients in the absence of any other resources. The medication assistance must be greater than 90 days.

RWHAP Part C or D recipients using this service category must establish the following:

  • A financial eligibility criteria and determination process for this specific service category
  • A drug formulary consisting of HIV primary care medications not otherwise available to the client
  • Implementation in accordance with the requirements of the 340B Drug Pricing Program and the Prime Vendor Program

Program Guidance:

For LPAPs: Only RWHAP Part A grant award funds or Part B Base award funds may be used to support an LPAP. ADAP funds may not be used for LPAP support. LPAP funds are not to be used for Emergency Financial Assistance. Emergency Financial Assistance may assist with medications not covered by the LPAP.

For Community Pharmaceutical Assistance: This service category should be used when RWHAP Part C or D funding is expended to routinely refill medications. RWHAP Part C or D recipients should use the Outpatient Ambulatory Health Services or Emergency Financial Assistance service for non-routine, short-term medication assistance.

See: Ryan White HIV/AIDS Program Part A and B National Monitoring Standards

See also: AIDS Drug Assistance Program Treatments and Emergency Financial Assistance

Number of Clients Served, Units Provided, Expenditures, Allocation, Over/Under-spending

Year 2016 2017 2018 2019 2020 2021 2022
Drug Reimbursement Clients 319 325 264 285 222 203
Drug Reimbursement Units 2,111 2,361 1,828 1,863 1,216 809
Drug Reimbursement Dollars $573,286 $505,196 $357,810 $486,328 $273,094 $422,390 $342,089
Allocated Dollars $516,000 $505,503 $497,810 $486,328 $483,762 $483,762 $480,992
Over/ Underspending $57,286 over $307 under $140,000 over $0 $210,668 under $61,372 $138,903 under

Funding by Part, and info on any other payers

Total Part A Funds (Formula + Supp.) MAI Total Part B Funds (Formula + Supp. NJ) Total Part B Funds (Formula + Supp. PA) Total Part C EIS Funds (State & Local) Total Part D Funds (State & Local) Total Part F Funds
Last Year Allocation $480,992
Current Allocation $468,501

Consumer survey info 2017 n=392

n Used in the last 12 months Needed but did not get (last 12 months)
Local AIDS Pharmaceutical Assistance 139 89.2% 10.8%

Community Survey 2022 Service Responses n=236

I never personally needed this service I needed this service and received it I needed but did not get this service I never heard of this service
Local AIDS Pharma Assistance 40.25% 29.66% 3.39% 5.08%

Unmet need

For the purposes of this document, need is based on the response of a consumer when asked if there was a service they needed. MMP interviews patients in care and asks consumers if they need a service and if they receive it. Client services unit data identifies needs at the time of initial intake.

2015-18 MMP Percent with a Need 2021 Client Services Unit Need at Intake
Local AIDS Pharmaceutical Assistance 1.3% 27.8%

Recipient Service Considerations

Local Pharma Assistance Program

19 (-8.6%) fewer clients had 326 (-26.8%) fewer 30-day Prescriptions filled. Accordingly, expenditures declined by 19.0%. Meanwhile, the cost of a unit of service in this category increased from $347.36 to $384.37(10.7%).

Due to more expedient processes related to SPBP and Medicaid, the need for this service continues to decline year over year.